Servicio de Microbiología Clínica. Hospital G.U. Gregorio Marañón
Hospital Universitario de la Princesa
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (44)
2023
-
Antifungal resistance in Candida spp within the intra-abdominal cavity: study of resistance acquisition in patients with serial isolates
Clinical Microbiology and Infection, Vol. 29, Núm. 12, pp. 1604.e1-1604.e6
-
Correction: Díaz-García et al. Candida Genotyping of Blood Culture Isolates from Patients Admitted to 16 Hospitals in Madrid: Genotype Spreading during the COVID-19 Pandemic Driven by Fluconazole-Resistant C. parapsilosis. J. Fungi 2022, 8, 1228
Journal of Fungi
-
Identification of Mycobacterium abscessus Subspecies by MALDI-TOF Mass Spectrometry and Machine Learning
Journal of clinical microbiology, Vol. 61, Núm. 1, pp. e0111022
-
Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper
Revista Espanola de Quimioterapia, Vol. 36, Núm. 1, pp. 1-25
-
Non-Candida isolates from blood cultures and intra-abdominal samples: data derived from a multicentre prospective study conducted in Madrid
Revista Espanola de Quimioterapia
-
Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis
Frontiers in Cellular and Infection Microbiology, Vol. 13
-
Trends in antifungal resistance in Candida from a multicenter study conducted in Madrid (CANDIMAD study): fluconazole-resistant C. parapsilosis spreading has gained traction in 2022
Antimicrobial Agents and Chemotherapy, Vol. 67, Núm. 11
2022
-
Blood and intra-abdominal Candida spp. from a multicentre study conducted in Madrid using EUCAST: emergence of fluconazole resistance in Candida parapsilosis, low echinocandin resistance and absence of Candida auris
The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 11, pp. 3102-3109
-
Candida Genotyping of Blood Culture Isolates from Patients Admitted to 16 Hospitals in Madrid: Genotype Spreading during the COVID-19 Pandemic Driven by Fluconazole-Resistant C. parapsilosis
Journal of Fungi, Vol. 8, Núm. 11
-
Evidence of Fluconazole-Resistant Candida parapsilosis Genotypes Spreading across Hospitals Located in Madrid, Spain and Harboring the Y132F ERG11p Substitution
Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 8
-
First confirmation of importation and transmission in Spain of the newly identified SARS-CoV-2 B.1.1.7 variant
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 10, pp. 546-549
-
Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)
The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 5, pp. 1452-1460
2021
-
In vitro activity of cefiderocol and comparators against isolates of Gram-negative bacterial pathogens from a range of infection sources: SIDERO‑WT‑2014−2018 studies in Spain
Journal of Global Antimicrobial Resistance, Vol. 26, pp. 292-300
2020
-
Prediction of poor outcome in Clostridioides difficile infection: A multicentre external validation of the toxin B amplification cycle
Anaerobe, Vol. 61
-
Work-related burnout syndrome in physicians in Spain
Revista Clinica Espanola, Vol. 220, Núm. 6, pp. 359-363
2019
-
Recommendations from a panel of experts on the usefulness of fidaxomicin for the treatment of infections caused by Clostridium difficile
Revista Espanola de Quimioterapia, Vol. 32, Núm. 1, pp. 50-59
-
Vaccines for the prevention of infections in adults: An opinion paper on the situation in Spain
Revista Espanola de Quimioterapia, Vol. 32, Núm. 4, pp. 333-364
2018
-
Dalbavancin in the treatment of different gram-positive infections: a real-life experience
International Journal of Antimicrobial Agents, Vol. 51, Núm. 4, pp. 571-577
-
Serotypes and genotypes of S. pneumoniae isolates from adult invasive disease in Spain: A 5-year prospective surveillance after pediatric PCV13 licensure. The ODIN study
Vaccine, Vol. 36, Núm. 52, pp. 7993-8000
2017
-
Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 12, pp. 3283-3287